Product Program year 2019 Source: CMS Open Payments

Folotyn

Drug Oncology

NDC 48818-001-01

Open in the dashboard

General payments

$13,948

195 payments

Research payments

$96,525

12 payments

Through program year 2019, $13,948 in general payments and $96,525 in research payments were reported against Folotyn (Oncology).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2019 General $13,948 195
2019 Research $96,525 12

Breakdown

Who paid General payments · program year 2019
  1. Spectrum Pharmaceuticals Inc. $13,948 195 payments
Top recipients General payments · program year 2019
  1. Matthew Lunning Medical Oncology · Omaha, NE $5,117 37% · 6 payments
  2. Presbyterian St. Lukes Medical Cent Teaching hospital · CO $1,800 13% · 1 payment
  3. Nilanjan Ghosh Medical Oncology · Charlotte, NC $1,300 9% · 2 payments
  4. Hospital Of The Univ Of Penna Teaching hospital · PA $1,200 9% · 1 payment
  5. Moffitt Cancer Center Teaching hospital · FL $600 4% · 1 payment

The top 5 of the 100 largest recipients; each share is of general payments naming this product in 2019.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2019
  1. Medical Oncology Internal Medicine $7,198 70% · 36 practitioners
  2. Hematology & Oncology Internal Medicine $2,390 23% · 101 practitioners
  3. Hematology Internal Medicine $140 1% · 3 practitioners
  4. Hospitalist $97 <1% · 1 practitioner
  5. Radiation Oncology Radiology $85 <1% · 6 practitioners

The top 5 of 21 specialties; each share is of general payments naming this product to practitioners with a specialty in 2019. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2019
  1. Nebraska $5,117 37% · 1 recipient
  2. Colorado $2,195 16% · 4 recipients
  3. Pennsylvania $1,492 11% · 21 recipients
  4. California $1,379 10% · 64 recipients
  5. North Carolina $1,324 9% · 2 recipients

The top 5 of 30 states; each share is of general payments naming this product in 2019 where a state was reported.

The top 25 states, free in the app

195 general · 12 research

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2019

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record